A randomised, crossover, single-dose, phase I trial of three different formulations of controlled release CTP 499 in healthy volunteers.

Trial Profile

A randomised, crossover, single-dose, phase I trial of three different formulations of controlled release CTP 499 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Oct 2011

At a glance

  • Drugs CTP 499 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Oct 2011 Results were presented at the American Society of Nephrology's (ASN) Kidney Week 2011, according to a Concert Pharmaceuticals media release.
    • 22 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top